Phoenix Biotech Acquisition Corp (PBAXU)

followers · Follow

Sector:

FINANCE

Industry:

GENERAL FINANCE

SIC:

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

CEO:

Christopher B. Ehrlich

Employees:

2001 MARKET STREET, SUITE 3400, PHILADELPHIA, PA, 19103

2157319450

N/A

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe.

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Phoenix Biotech Acquisition Corp YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available